Results 341 to 350 of about 176,113 (383)
Some of the next articles are maybe not open access.

European expert consensus statement on the systemic treatment of alopecia areata

Journal of the European Academy of Dermatology and Venereology
Alopecia areata is an autoimmune form of non‐scarring hair loss. It is usually characterized by limited areas of hair loss. However, the disease may progress to complete scalp and body hair loss (alopecia totalis, alopecia universalis).
L. Rudnicka   +17 more
semanticscholar   +1 more source

Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers

Journal of the European Academy of Dermatology and Venereology, 2020
Alopecia areata is a T‐cell‐mediated autoimmune disease with an unknown etiopathogenesis. Gut microbiota has been revealed as a key modulator of systemic immunity.
O. Moreno‐Arrones   +8 more
semanticscholar   +1 more source

Alopecia areata: a review of disease pathogenesis

British Journal of Dermatology, 2018
Alopecia areata is a disorder that results in nonscarring hair loss. The psychological impact can be significant, leading to feelings of depression and social isolation.
Fateme Rajabi   +5 more
semanticscholar   +1 more source

Alopecia areata

International Journal of Dermatology, 2007
AbstractAlopecia areata (AA) is a nonscarring, autoimmune, inflammatory, hair loss on the scalp, and/or body. Etiology and pathogenesis are still unknown. The most common site affected is the scalp. Histopathology is characterized by an increased number of the catagen and telogen follicles, the presence of inflammatory lymphocytic infiltrate in the ...
Amy J. McMichael   +3 more
openaire   +3 more sources

Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review

International Journal of Dermatology, 2020
Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off‐label use of low‐dose oral minoxidil.
A. N. Sharma   +4 more
semanticscholar   +1 more source

Comorbidities in pediatric alopecia areata

Journal of the European Academy of Dermatology and Venereology, 2020
Comorbidities are associated with higher health care costs, complex management, and poorer health outcomes. Identification and treatment of comorbid conditions in paediatric alopecia areata (AA) patients could provide an opportunity to improve health ...
R. Conic   +5 more
semanticscholar   +1 more source

PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)

2021
Alopecia areata (AA) is a common cause of non-cicatricial hair loss with a sudden, unpredictable, and recurrent course that is associated with significant psychosocial burden. Current treatment options, such as topical and intralesional corticosteroids, systemic immunosuppression, topical immunotherapy, and Janus Kinase Inhibitors (JAK inhibitors ...
Jeffrey S. Dover, Nina Semsarzadeh
openaire   +2 more sources

Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing

British Journal of Dermatology, 2020
Frontal fibrosing alopecia (FFA) is a scarring alopecia with unclear pathogenesis and a progressive course. The disease has a major impact on patients’ quality of life and there is a lack of effective treatment to halt disease progression.
E. D. Duca   +16 more
semanticscholar   +1 more source

Psoriatic alopecia

Clinical and Experimental Dermatology, 2015
Alopecia and other hair abnormalities occurring in patients with psoriasis were first recognized over four decades ago, yet psoriatic alopecia is not a well-known concept among clinicians. Alopecia may be directly related to the psoriasis itself, and can affect both the scalp and other parts of the body.
M. R. Taylor   +2 more
openaire   +3 more sources

Alopecia Areata: Current Treatments and New Directions

American Journal of Clinical Dermatology, 2023
D. Dahabreh   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy